Literature DB >> 20640470

Guillain-Barré syndrome as an atypical manifestation of an esophageal carcinoma.

T Zilli1, A S Allal.   

Abstract

Guillain-Barré syndrome (GBS) is an acute demyelinating polyradiculoneuropathy normally associated with a preceding infection, but sometimes it can be linked to a subjacent malignancy. We report an unusual case of GBS occurring as the first clinical manifestation of an esophageal adenocarcinoma in a 65-year-old patient. A GBS neuropathy of undetermined origin may be associated with an underlying tumor and esophageal cancer has to be considered in the differential diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20640470     DOI: 10.1007/s10072-010-0363-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies.

Authors:  R P Lisak; M Mitchell; B Zweiman; E Orrechio; A K Asbury
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

2.  Motor neuron syndromes in cancer patients.

Authors:  P A Forsyth; J Dalmau; F Graus; V Cwik; M K Rosenblum; J B Posner
Journal:  Ann Neurol       Date:  1997-06       Impact factor: 10.422

Review 3.  The immunobiology of Guillain-Barré syndromes.

Authors:  Hugh J Willison
Journal:  J Peripher Nerv Syst       Date:  2005-06       Impact factor: 3.494

4.  Polyradiculoneuritis as an initial manifestation of bronchial carcinoma.

Authors:  T C Mineo; F Biancari; C U Casciani
Journal:  J Thorac Cardiovasc Surg       Date:  1995-06       Impact factor: 5.209

5.  Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.

Authors:  J C Antoine; J F Mosnier; L Absi; P Convers; J Honnorat; D Michel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

6.  Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer.

Authors:  L M Tho; C P O'Leary; I Horrocks; A Al-Ani; N S Reed
Journal:  Gynecol Oncol       Date:  2005-10-20       Impact factor: 5.482

7.  Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma.

Authors:  D Re; A Schwenk; P Hegener; S Bamborschke; V Diehl; H Tesch
Journal:  Ann Oncol       Date:  2000-02       Impact factor: 32.976

8.  Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy.

Authors:  C Christodoulou; D Anastasopoulos; A Visvikis; S Mellou; I Detsi; G Tsiakalos; A Pateli; G Klouvas; A Papadimitriou; D V Skarlos
Journal:  Anticancer Drugs       Date:  2004-11       Impact factor: 2.248

9.  Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis.

Authors:  J Hallas; J Halls; C Bredkjaer; M L Friis
Journal:  Acta Neurol Scand       Date:  1988-08       Impact factor: 3.209

10.  Guillain-Barre syndrome following autologous bone marrow transplantation.

Authors:  R Mudad; A Hussein; W P Peters
Journal:  Am J Clin Oncol       Date:  1995-04       Impact factor: 2.339

View more
  3 in total

1.  Melanoma metastasis to the gastric mucosa preceded by guillain-barré as a paraneoplastic syndrome.

Authors:  Rodrigo Kraft Rovere; Maria Eduarda Pires de Souza; Sara Fernanda Hilgert; Yasmine Rodrigues Chamse Ddine; Adma Silva de Lima
Journal:  Gastrointest Cancer Res       Date:  2013-09

2.  A Case of Paraneoplastic Guillain-Barré Syndrome Associated with Squamous Cell Carcinoma of the Lung.

Authors:  Danwei Wu; Anne Liu; Esther Baldinger; Alfred T Frontera
Journal:  Cureus       Date:  2018-08-24

3.  Cancer Diagnosis and Prognosis After Guillain-Barré Syndrome: A Population-Based Cohort Study.

Authors:  Blean Girma; Dóra Körmendiné Farkas; Kristina Laugesen; Nils Skajaa; Victor W Henderson; Paolo Boffetta; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2022-07-19       Impact factor: 5.814

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.